A tissue biopsy is routinely sent for molecular testing to identify specific somatic mutations, gene translocations, or protein overexpression patterns that drive various cancers and genetic disorders. This advanced genomic analysis provides crucial prognostic data and uncovers actionable biomarkers, allowing oncologists to match patients with targeted therapies or immunotherapies tailored specifically to the unique molecular profile of their tumor.